| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Laboratory Medicine and Pathology [S. N. T., A. J. F., P. C. R., J. M. C., D. J. T., L. J. B., R. H., K. C. H.] and Department of Medical Genetics [N. M. L.], Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905; University of Dusseldorf, Dusseldorf, Germany [G. M.]; and Department of Molecular and Medical Genetics, Oregon Health Science University, Portland, Oregon 97207 [S. M. B., R. M. L.]
To date, at least four genes involved in DNA mismatch repair (MMR) have been demonstrated to be altered in the germline of patients with hereditary nonpolyposis colon cancer: hMSH2, hMLH1, hPMS1, and hPMS2. Additionally, loss of MMR function has been demonstrated to lead to the phenomenon of microsatellite instability (MIN) in tumors from these patients. In this study, we have examined the protein expression pattern of hMSH2 and hMLH1 by immunohistochemistry in paraffin-embedded tumors from 7 patients with MIN+ sporadic cancer, 13 patients with familial colorectal cancer, and 12 patients meeting the strict Amsterdam criteria for hereditary nonpolyposis colon cancer. The relationship between the expression of these two gene products, the presence of germline or somatic mutations, and the presence of tumor MIN was examined. Nineteen of the 28 tumors studied demonstrated MIN, whereas mutations in hMLH1 and hMSH2 were detected in 6 and 2 patients, respectively. Of the eight MIN+/mutation+ cases, the absence of protein expression was observed for the corresponding gene product in all but one case (missense mutation in hMLH1). However, seven MIN+/mutation- cases also showed no expression of either hMLH1 (n = 5), hMSH2 (n = 1), or both (n = 1), whereas four MIN+/mutation- cases demonstrated normal expression for both. None of the MIN-/mutation- cases (n = 9) demonstrated an altered expression pattern for either protein. These data suggest that examination of protein expression by immunohistochemistry may be a rapid method for prescreening tumors for mutations in the MMR genes.
1 This work was supported by NIH Grant CA 68535-2.
2 To whom requests for reprints should be addressed, at Laboratory Genetics/HI 970, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Phone: (507) 284-4696.
3 G. M. was funded by Deutsche Forschungsgemeinschaft.
4 Current affiliation: Indiana University, Indianapolis, IN 46236.
5 Current affiliation: R. L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN 46236.
Received 7/26/96. Accepted 9/18/96.
This article has been cited by other articles:
![]() |
E. M. Grindedal, P. Moller, R. Eeles, A. T. Stormorken, I. M. Bowitz-Lothe, S. M. Landro, N. Clark, R. Kvale, S. Shanley, and L. Maehle Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2460 - 2467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Pino, M. Mino-Kenudson, B. M. Wildemore, A. Ganguly, J. Batten, I. Sperduti, A. J. Iafrate, and D. C. Chung Deficient DNA Mismatch Repair Is Common in Lynch Syndrome-Associated Colorectal Adenomas J. Mol. Diagn., May 1, 2009; 11(3): 238 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bianchi, E. Galizia, R. Catalani, L. Belvederesi, C. Ferretti, F. Corradini, and R. Cellerino CAT25 Is a Mononucleotide Marker to Identify HNPCC Patients J. Mol. Diagn., May 1, 2009; 11(3): 248 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Bertagnolli, R. S. Warren, D. Niedzwiecki, E. Mueller, C. C. Compton, M. Redston, M. Hall, H. P. Hahn, S. D. Jewell, R. J. Mayer, et al. p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803 Clin. Cancer Res., March 15, 2009; 15(6): 2116 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Permuth-Wey, D. Boulware, N. Valkov, S. Livingston, S. Nicosia, J.-H. Lee, R. Sutphen, J. Schildkraut, S. Narod, A. Parker, et al. Sampling Strategies for Tissue Microarrays to Evaluate Biomarkers in Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hampel, W. L. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, M. Clendenning, K. Sotamaa, T. Prior, J. A. Westman, et al. Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer J. Clin. Oncol., December 10, 2008; 26(35): 5783 - 5788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. South, H. Hampel, I. Comeras, J. A. Westman, W. L. Frankel, and A. de la Chapelle The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families J Natl Cancer Inst, February 20, 2008; 100(4): 277 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Jacinto and M. Esteller Mutator pathways unleashed by epigenetic silencing in human cancer Mutagenesis, July 1, 2007; 22(4): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lagerstedt Robinson, T. Liu, J. Vandrovcova, B. Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, P. Peltomaki, et al. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics J Natl Cancer Inst, February 21, 2007; 99(4): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes J. Clin. Oncol., October 1, 2006; 24(28): 4642 - 4660. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M.C. Hendriks, A. E. de Jong, H. Morreau, C. M.J. Tops, H. F. Vasen, J. Th. Wijnen, M. H. Breuning, and A. H.J.T. Brocker-Vriends Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians CA Cancer J Clin, July 1, 2006; 56(4): 213 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuzaki, G. Deng, H. Tanaka, S. Kakar, S. Miura, and Y. S. Kim The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer Clin. Cancer Res., December 15, 2005; 11(24): 8564 - 8569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Hussein, A. K. Haemel, D. M. Albert, and G. S. Wood Microsatellite Instability and Alterations of Mismatch Repair Protein Expression in Choroidal Melanomas Arch Ophthalmol, December 1, 2005; 123(12): 1705 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Southey, M. A. Jenkins, L. Mead, J. Whitty, M. Trivett, A. A. Tesoriero, L. D. Smith, K. Jennings, G. Grubb, S. G. Royce, et al. Use of Molecular Tumor Characteristics to Prioritize Mismatch Repair Gene Testing in Early-Onset Colorectal Cancer J. Clin. Oncol., September 20, 2005; 23(27): 6524 - 6532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Stormorken, I. M. Bowitz-Lothe, T. Noren, E. Kure, S. Aase, J. Wijnen, J. Apold, K. Heimdal, and P. Moller Immunohistochemistry Identifies Carriers of Mismatch Repair Gene Defects Causing Hereditary Nonpolyposis Colorectal Cancer J. Clin. Oncol., July 20, 2005; 23(21): 4705 - 4712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giuffre, A. Muller, T. Brodegger, T. Bocker-Edmonston, J. Gebert, M. Kloor, W. Dietmaier, F. Kullmann, R. Buttner, G. Tuccari, et al. Microsatellite Analysis of Hereditary Nonpolyposis Colorectal Cancer-Associated Colorectal Adenomas by Laser-Assisted Microdissection: Correlation with Mismatch Repair Protein Expression Provides New Insights in Early Steps of Tumorigenesis J. Mol. Diagn., May 1, 2005; 7(2): 160 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pinol, A. Castells, M. Andreu, S. Castellvi-Bel, C. Alenda, X. Llor, R. M. Xicola, F. Rodriguez-Moranta, A. Paya, R. Jover, et al. Accuracy of Revised Bethesda Guidelines, Microsatellite Instability, and Immunohistochemistry for the Identification of Patients With Hereditary Nonpolyposis Colorectal Cancer JAMA, April 27, 2005; 293(16): 1986 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Singh, H. S. Mudhar, R. Bhola, P. A. Rundle, and I. G. Rennie Sebaceous Adenoma of the Eyelid in Muir-Torre Syndrome Arch Ophthalmol, April 1, 2005; 123(4): 562 - 565. [Full Text] [PDF] |
||||
![]() |
S. Oda, Y. Maehara, Y. Ikeda, E. Oki, A. Egashira, Y. Okamura, I. Takahashi, Y. Kakeji, Y. Sumiyoshi, K. Miyashita, et al. Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability Nucleic Acids Res., March 18, 2005; 33(5): 1628 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Boman, R. Walters, J. Z. Fields, A. J. Kovatich, T. Zhang, G. A. Isenberg, S. D. Goldstein, and J. P. Palazzo Colonic Crypt Changes during Adenoma Development in Familial Adenomatous Polyposis: Immunohistochemical Evidence for Expansion of the Crypt Base Cell Population Am. J. Pathol., November 1, 2004; 165(5): 1489 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Caluseriu, C Di Gregorio, E Lucci-Cordisco, M Santarosa, J Trojan, A Brieger, P Benatti, M Pedroni, T Colibazzi, A Bellacosa, et al. A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability J. Med. Genet., March 1, 2004; 41(3): e34 - 34. [Full Text] [PDF] |
||||
![]() |
A. E. de Jong, M. van Puijenbroek, Y. Hendriks, C. Tops, J. Wijnen, M. G. E. M. Ausems, H. Meijers-Heijboer, A. Wagner, T. A. M. van Os, A. H. J. T. Brocker-Vriends, et al. Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer Clin. Cancer Res., February 1, 2004; 10(3): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Renkonen, Y. Zhang, H. Lohi, R. Salovaara, W. M. Abdel-Rahman, M. Nilbert, K. Aittomaki, H. J. Jarvinen, J.-P. Mecklin, A. Lindblom, et al. Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3629 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility J. Clin. Oncol., June 15, 2003; 21(12): 2397 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H J Jarvinen Genetic testing for polyposis: practical and ethical aspects Gut, May 1, 2003; 52(90002): ii19 - 22. [Abstract] [Full Text] |
||||
![]() |
Y. Hendriks, P. Franken, J. W. Dierssen, W. de Leeuw, J. Wijnen, E. Dreef, C. Tops, M. Breuning, A. Brocker-Vriends, H. Vasen, et al. Conventional and Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair in Hereditary Colorectal Tumors Am. J. Pathol., February 1, 2003; 162(2): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Theuer, B. S. Campbell, D. J. Peel, F. Lin, P. Carpenter, A. Ziogas, and J. A. Butler Microsatellite Instability in Japanese vs European American Patients With Gastric Cancer Arch Surg, August 1, 2002; 137(8): 960 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kucherlapati, K. Yang, M. Kuraguchi, J. Zhao, M. Lia, J. Heyer, M. F. Kane, K. Fan, R. Russell, A. M. C. Brown, et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression PNAS, July 23, 2002; 99(15): 9924 - 9929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wahlberg, J. Schmeits, G. Thomas, M. Loda, J. Garber, S. Syngal, R. D. Kolodner, and E. Fox Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-Line MSH2 and MLH1 Mutations in Hereditary Nonpolyposis Colon Cancer Families Cancer Res., June 1, 2002; 62(12): 3485 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. A.-E. Hussein and G. S. Wood Molecular Aspects of Melanocytic Dysplastic Nevi J. Mol. Diagn., May 1, 2002; 4(2): 71 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scartozzi, F. Bianchi, S. Rosati, E. Galizia, A. Antolini, C. Loretelli, A. Piga, I. Bearzi, R. Cellerino, and E. Porfiri Mutations of hMLH1 and hMSH2 in Patients With Suspected Hereditary Nonpolyposis Colorectal Cancer: Correlation With Microsatellite Instability and Abnormalities of Mismatch Repair Protein Expression J. Clin. Oncol., March 1, 2002; 20(5): 1203 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
F E M Rijcken, H Hollema, and J H Kleibeuker Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation Gut, March 1, 2002; 50(3): 382 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Raymond, S. Faivre, S. Chaney, J. Woynarowski, and E. Cvitkovic Cellular and Molecular Pharmacology of Oxaliplatin Mol. Cancer Ther., January 1, 2002; 1(3): 227 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Devouassoux-Shisheboran, C. Mauduit, R. Bouvier, F. Berger, M. Bouras, J. P. Droz, and M. Benahmed Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours Mol. Hum. Reprod., December 1, 2001; 7(12): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ward, A Meagher, I Tomlinson, T O'Connor, M Norrie, R Wu, and N Hawkins Microsatellite instability and the clinicopathological features of sporadic colorectal cancer Gut, June 1, 2001; 48(6): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hyun Song, H.-S. Jong, H. H. Choi, H. Inoue, T. Tanabe, N. K. Kim, and Y.-J. Bang Transcriptional Silencing of Cyclooxygenase-2 by Hyper-methylation of the 5' CpG Island in Human Gastric Carcinoma Cells Cancer Res., June 1, 2001; 61(11): 4628 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J G Stone, D Robertson, and R S Houlston Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer J. Clin. Pathol., June 1, 2001; 54(6): 484 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-G. Kim, Y. R. Choi, M. J. Baek, Y. H. Kim, H. Kang, N. K. Kim, J. S. Min, and H. Kim Frameshift Mutations at Coding Mononucleotide Repeats of the hRAD50 Gene in Gastrointestinal Carcinomas with Microsatellite Instability Cancer Res., January 1, 2001; 61(1): 36 - 38. [Abstract] [Full Text] |
||||
![]() |
H. F. A. Vasen Clinical Diagnosis and Management of Hereditary Colorectal Cancer Syndromes J. Clin. Oncol., November 1, 2000; 18(90001): 81s - 92. [Full Text] [PDF] |
||||
![]() |
A. S. Fleisher, M. Esteller, N. Harpaz, A. Leytin, A. Rashid, Y. Xu, J. Liang, O. C. Stine, J. Yin, T.-T. Zou, et al. Microsatellite Instability in Inflammatory Bowel Disease-associated Neoplastic Lesions Is Associated with Hypermethylation and Diminished Expression of the DNA Mismatch Repair Gene, hMLH1 Cancer Res., September 1, 2000; 60(17): 4864 - 4868. [Abstract] [Full Text] |
||||
![]() |
Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax Expression in Invasive and in Situ Squamous Cell Carcinoma of the Uterine Cervix Clin. Cancer Res., September 1, 2000; 6(9): 3600 - 3606. [Abstract] [Full Text] |
||||
![]() |
G. Xinarianos, T. Liloglou, W. Prime, P. Maloney, J. Callaghan, P. Fielding, J. R. Gosney, and J. K. Field hMLH1 and hMSH2 Expression Correlates with Allelic Imbalance on Chromosome 3p in Non-Small Cell Lung Carcinomas Cancer Res., August 1, 2000; 60(15): 4216 - 4221. [Abstract] [Full Text] |
||||
![]() |
J M D Wheeler, A Loukola, L A Aaltonen, N J M. Mortensen, and W F Bodmer The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers J. Med. Genet., August 1, 2000; 37(8): 588 - 592. [Abstract] [Full Text] |
||||
![]() |
J M D WHEELER, W F BODMER, and N J M. MORTENSEN DNA mismatch repair genes and colorectal cancer Gut, July 1, 2000; 47(1): 148 - 153. [Full Text] [PDF] |
||||
![]() |
J.-W. Chang, Y.-C. Chen, C.-Y. Chen, J.-T. Chen, S.-K. Chen, and Y.-C. Wang Correlation of Genetic Instability with Mismatch Repair Protein Expression and p53 Mutations in Non-Small Cell Lung Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1639 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wilentz, M. Goggins, M. Redston, V. A. Marcus, N. V. Adsay, T. A. Sohn, S. S. Kadkol, C. J. Yeo, M. Choti, M. Zahurak, et al. Genetic, Immunohistochemical, and Clinical Features of Medullary Carcinoma of the Pancreas : A Newly Described and Characterized Entity Am. J. Pathol., May 1, 2000; 156(5): 1641 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Esteller, J. M. Silva, G. Dominguez, F. Bonilla, X. Matias-Guiu, E. Lerma, E. Bussaglia, J. Prat, I. C. Harkes, E. A. Repasky, et al. Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors J Natl Cancer Inst, April 5, 2000; 92(7): 564 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Parc, K. C. Halling, L. Wang, E. R. Christensen, J. M. Cunningham, A. J. French, L. J. Burgart, T. L. Price-Troska, P. C. Roche, and S. N. Thibodeau hMSH6 Alterations in Patients with Microsatellite Instability-Low Colorectal Cancer Cancer Res., April 1, 2000; 60(8): 2225 - 2231. [Abstract] [Full Text] |
||||
![]() |
D. S. Middlemas, C. F. Stewart, M. N Kirstein, C. Poquette, H. S. Friedman, P. J. Houghton, and T. P. Brent Biochemical Correlates of Temozolomide Sensitivity in Pediatric Solid Tumor Xenograft Models Clin. Cancer Res., March 1, 2000; 6(3): 998 - 1007. [Abstract] [Full Text] |
||||
![]() |
H. J. Mackay, D. Cameron, M. Rahilly, M. J. Mackean, J. Paul, S. B. Kaye, and R. Brown Reduced MLH1 Expression in Breast Tumors After Primary Chemotherapy Predicts Disease-Free Survival J. Clin. Oncol., January 5, 2000; 18(1): 87 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lal, G. Liu, B. Schmocker, P. Kaurah, H. Ozcelik, S. A. Narod, M. Redston, and S. Gallinger Inherited Predisposition to Pancreatic Adenocarcinoma: Role of Family History and Germ-Line p16, BRCA1, and BRCA2 Mutations Cancer Res., January 1, 2000; 60(2): 409 - 416. [Abstract] [Full Text] |
||||
![]() |
L Cawkwell, S Gray, H Murgatroyd, F Sutherland, L Haine, M Longfellow, S O'Loughlin, D Cross, O Kronborg, C Fenger, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair Gut, September 1, 1999; 45(3): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verma, M. F Kane, C. Brassett, J. Schmeits, D G. R Evans, R. D Kolodner, and E. R Maher Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer J. Med. Genet., September 1, 1999; 36(9): 678 - 682. [Abstract] [Full Text] |
||||
![]() |
J. M. D. Wheeler, N. E. Beck, H. C. Kim, I. P. M. Tomlinson, N. J. McC. Mortensen, and W. F. Bodmer Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1 PNAS, August 31, 1999; 96(18): 10296 - 10301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Curia, R. Palmirotta, G. Aceto, L. Messerini, M. C. Veri, S. Crognale, R. Valanzano, F. Ficari, P. Fracasso, V. Stigliano, et al. Unbalanced Germ-Line Expression of hMLH1 and hMSH2 Alleles in Hereditary Nonpolyposis Colorectal Cancer Cancer Res., August 1, 1999; 59(15): 3570 - 3575. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Zhu, E.P. Das-Gupta, and N.H. Russell Microsatellite Instability and p53 Mutations Are Associated With Abnormal Expression of the MSH2 Gene in Adult Acute Leukemia Blood, July 15, 1999; 94(2): 733 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
I M FRAYLING Microsatellite instability Gut, July 1, 1999; 45(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
M P. de Leon, M Pedroni, P Benatti, A Percesepe, C Di Gregorio, M Foroni, G Rossi, M Genuardi, G Neri, F Leonardi, et al. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis Gut, July 1, 1999; 45(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Halling, J. Harper, C. A. Moskaluk, S. N. Thibodeau, G. R. Petroni, A. S. Yustein, P. Tosi, C. Minacci, F. Roviello, P. Piva, et al. Origin of Microsatellite Instability in Gastric Cancer Am. J. Pathol., July 1, 1999; 155(1): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deng, A. Chen, J. Hong, H. S. Chae, and Y. S. Kim Methylation of CpG in a Small Region of the hMLH1 Promoter Invariably Correlates with the Absence of Gene Expression Cancer Res., May 1, 1999; 59(9): 2029 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Fleisher, M. Esteller, S. Wang, G. Tamura, H. Suzuki, J. Yin, T.-T. Zou, J. M. Abraham, D. Kong, K. N. Smolinski, et al. Hypermethylation of the hMLH1 Gene Promoter in Human Gastric Cancers with Microsatellite Instability Cancer Res., March 1, 1999; 59(5): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Leung, S. T. Yuen, L. P. Chung, K. M. Chu, A. S. Y. Chan, and J. C. I. Ho hMLH1 Promoter Methylation and Lack of hMLH1 Expression in Sporadic Gastric Carcinomas with High-Frequency Microsatellite Instability Cancer Res., January 1, 1999; 59(1): 159 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujiwara, J. M. Stolker, T. Watanabe, A. Rashid, P. Longo, J. R. Eshleman, S. Booker, H. T. Lynch, J. R. Jass, J. S. Green, et al. Accumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas with Widespread Instability in Microsatellite Sequences Am. J. Pathol., October 1, 1998; 153(4): 1063 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al. The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells Blood, August 1, 1998; 92(3): 1011 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Herman, A. Umar, K. Polyak, J. R. Graff, N. Ahuja, J.-P. J. Issa, S. Markowitz, J. K. V. Willson, S. R. Hamilton, K. W. Kinzler, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma PNAS, June 9, 1998; 95(12): 6870 - 6875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De las Alas, R. A. M. de bruin, L. T. Eyck, G. Los, and S. B. Howell Prediction-based threading of the hMSH2 DNA mismatch repair protein FASEB J, June 1, 1998; 12(9): 653 - 663. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |